These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19803946)

  • 1. Emerging role of inhibin as a biomarker for ovarian cancer.
    Robertson DM; Oehler MK
    Womens Health (Lond); 2005 Jul; 1(1):51-7. PubMed ID: 19803946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibins/activins as diagnostic markers for ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; Burger HG; McCloud P; Tsigos A; Groome N; Mamers P; McNeilage J; Jobling T; Healy D
    Mol Cell Endocrinol; 2002 May; 191(1):97-103. PubMed ID: 12044923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibins and ovarian cancer.
    Robertson DM; Pruysers E; Burger HG; Jobling T; McNeilage J; Healy D
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):65-71. PubMed ID: 15451569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total inhibin is a potential serum marker for epithelial ovarian cancer.
    Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
    Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
    Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
    Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
    N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin as a diagnostic marker for ovarian cancer.
    Robertson DM; Pruysers E; Jobling T
    Cancer Lett; 2007 Apr; 249(1):14-7. PubMed ID: 17320281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of total inhibin in diagnosis and monitoring of ovarian cancer in postmenopausal women].
    Markova D; Milchev N; Batashki I; Uchikov A
    Akush Ginekol (Sofiia); 2008; 47(1):16-9. PubMed ID: 18642569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
    Cathro HP; Stoler MH
    Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibin as a marker for granulosa-cell tumors.
    Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M; de Bruijn HW
    N Engl J Med; 1989 Sep; 321(12):790-3. PubMed ID: 2770810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibin subunit gene expression in ovarian cancer.
    Fuller PJ; Chu S; Jobling T; Mamers P; Healy DL; Burger HG
    Gynecol Oncol; 1999 May; 73(2):273-9. PubMed ID: 10329046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors.
    Petraglia F; Luisi S; Pautier P; Sabourin JC; Rey R; Lhomme C; Bidart JM
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1029-32. PubMed ID: 9506769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.
    Gurusinghe CJ; Healy DL; Jobling T; Mamers P; Burger HG
    Gynecol Oncol; 1995 Apr; 57(1):27-32. PubMed ID: 7705698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibins as biomarkers for reproductive cancers.
    Robertson DM; McNeilage J
    Semin Reprod Med; 2004 Aug; 22(3):219-25. PubMed ID: 15319824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibin/activin family and ovarian cancer.
    Burger HG; Fuller PJ
    Trends Endocrinol Metab; 1996 Aug; 7(6):197-202. PubMed ID: 18406747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
    Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
    Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.